The mechanisms triggering mitochondrial translocation to engage this non-canonical role of STAT3 have to be further investigated to provide clearer insights on how canonical and non-canonical function can be utilized effectively in immunotherapy cancer therapeutics [80]. The gene discussed is STAT3; the disease is cancer.